About 5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole
5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole (PubChem CID 159949525) has the molecular formula C102H100BrF3N18O8
and a molecular weight of 1842.94 g/mol. Its IUPAC name is 5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole.
Frequently Asked Questions
What is the IUPAC name of 5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole?
The IUPAC name of 5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole (CID 159949525) is 5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole.
What is the SMILES notation for 5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole?
The canonical SMILES for 5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole is CC(C)Cc1ccc(C(C)c2nc(-c3ccncc3)no2)cc1.CCC(c1ccccc1)c1nc(-c2ccncc2)no1.CCOc1ccc(-c2nc(-c3cccc4[nH]ccc34)no2)cc1OCC.Cc1cnccc1-c1noc(C(C)c2ccc(CC(C)C)cc2)n1.FC(F)(F)c1cc(Br)cc(-c2nc(-c3ccncc3)no2)c1.c1cc(-c2noc(C3CCCCC3)n2)ccn1.
What is the InChIKey of 5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole?
The InChIKey is OBXSEECNOUPIAP-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H19N3O3.C20H23N3O.C19H21N3O.C16H15N3O.C14H7BrF3N3O.C13H15N3O/c1-3-24-17-9-8-13(12-18(17)25-4-2)20-22-19(23-26-20)15-6-5-7-16-14(15)10-11-21-16;1-13(2)11-16-5-7-17(8-6-16)15(4)20-22-19(23-24-20)18-9-10-21-12-14(18)3;1-13(2)12-15-4-6-16(7-5-15)14(3)19-21-18(22-23-19)17-8-10-20-11-9-17;1-2-14(12-6-4-3-5-7-12)16-18-15(19-20-16)13-8-10-17-11-9-13;15-11-6-9(5-10(7-11)14(16,17)18)13-20-12(21-22-13)8-1-3-19-4-2-8;1-2-4-11(5-3-1)13-15-12(16-17-13)10-6-8-14-9-7-10/h5-12,21H,3-4H2,1-2H3;5-10,12-13,15H,11H2,1-4H3;4-11,13-14H,12H2,1-3H3;3-11,14H,2H2,1H3;1-7H;6-9,11H,1-5H2.
What are the key properties of 5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole?
5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole has a molecular weight of 1842.94 g/mol, XLogP of 25.39, 24 rotatable bonds, 1 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[3-bromo-5-(trifluoromethyl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-cyclohexyl-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(1H-indol-4-yl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole;5-(1-phenylpropyl)-3-pyridin-4-yl-1,2,4-oxadiazole is sourced from PubChem (CID 159949525), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).